Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2017Clinical and Experimental Pharmacology and Physiology

Gastric cancer management: Kinases as a target therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

BFBatoul FarranHenry Ford Health SystemSMSusanne MüllerUniversity of StuttgartRMRaquel Carvalho MontenegroUniversidade Federal do Ceará

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Farran et al. (2017) studied this question.

synapsesocial.com/papers/6a9e6b4d67d34f09a3f9b6fdhttps://doi.org/10.1111/1440-1681.12743
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comprehensive molecular characterization of gastric adenocarcinoma2014 · 6,700 citations
  2. 2Personalized medicine in gastric cancer: Where are we and where are we going?2016 · 46 citations
  3. 3FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study2014 · 192 citations
  4. 4Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer2014 · 116 citations